IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NRX Pharmaceuticals Inc

CUSIP: 629444118 | 15 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

Wolverine Asset Management LLC23,593
0.0% of portfolio›$347
UBS Group AG13
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Wolverine Asset Management LLC
23,593$3470.0%Deep ValueVery HighChicago, IL2026-05-04
UBS Group AG
13$00.0%CoreMediumZurich, Switzerland2026-05-05